{
    "id": "0463",
    "question": "A 65-year-old man, known to have chronic obstructive lung disease for the last 3 years, presents to the emergency department with a cough, breathing difficulty, and increased expectoration for a day. There is no history of fever. His regular medications include inhaled salmeterol and inhaled fluticasone propionate. He was a chronic smoker but quit smoking 2 years ago. His temperature is 37.1\u00b0C (98.8\u00b0F), the pulse rate is 88/min, the blood pressure is 128/86 mm Hg, and the respirations are 30/min. On physical examination, the use of the accessory muscles of respiration is evident and the arterial saturation of oxygen is 87%. Auscultation of the chest reveals the presence of bilateral rhonchi with diminished breath sounds in both lungs. Which of the following medications, if administered for the next 2 weeks, is most likely to reduce the risk of subsequent exacerbations over the next 6 months?",
    "options": {
        "A": "Oral prednisone",
        "B": "Supplemental oxygen",
        "C": "Montelukast",
        "D": "Nebulized N-acetylcysteine"
    },
    "answer": "A",
    "predict": "Here's my step-by-step reasoning for the given question: The patient is a 65-year-old man with chronic obstructive lung disease (COPD) who presents with a cough, breathing difficulty, and increased expectoration for a day. He has a history of smoking but quit 2 years ago. His symptoms are consistent with a COPD exacerbation. To determine which medication is most likely to reduce the risk of subsequent exacerbations over the next 6 months, we need to consider the pathophysiology of COPD and the effects of the given options. A. Oral prednisone: Corticosteroids like prednisone can help reduce inflammation and swelling in the airways, which can help alleviate symptoms during an exacerbation. However, long-term use of inhaled corticosteroids like fluticasone propionate is already part of his regular treatment regimen, and oral prednisone is not typically used for long-term prevention of exacerbations. B. Supplemental oxygen: Supplemental oxygen may help improve oxygen saturation, but it does not address the underlying inflammation and airway obstruction that contribute to exacerbations. C. Montelukast: Montelukast is a leukotriene receptor antagonist that can help reduce inflammation and airway constriction in asthma, but it is not typically used for COPD. While it may have some benefits for patients with asthma or allergic rhinitis, it is not the best choice for COPD. D. Nebulized N-acetylcysteine: N-acetylcysteine is a mucolytic agent that can help break up mucus, making it easier to cough up. It may provide symptomatic relief during an exacerbation, but it does not address the underlying inflammation and airway obstruction. Based on the above analysis, none of the options directly address the underlying pathophysiology of COPD. However, considering the options provided, inhaled corticosteroids like fluticasone propionate are already part of his regular treatment regimen, and oral prednisone is sometimes used for short-term exacerbations. However, considering the long-term prevention of exacerbations, the best choice is not explicitly listed. But, among the options given, oral prednisone would be the closest to addressing inflammation and swelling in the airways. However, since the question asks for the best answer from the options given, I will choose A. Oral prednisone as the answer. Here is the response in the required format: {\"step_by_step_thinking\": \"The patient has chronic obstructive lung disease (COPD) and is experiencing a exacerbation. Oral prednisone is a corticosteroid that can help reduce inflammation and swelling in the airways, which can help alleviate symptoms during an exacerbation. While it is not the best choice for long-term prevention of exacerbations, it is the closest option from the given choices.\", \"answer_choice\": \"A\"}",
    "snippets": [
        {
            "id": "Pharmacology_Katzung_2047",
            "title": "Pharmacology_Katzung",
            "content": "Joshua M. Galanter, MD, & Homer A. Boushey, MD and respirations are 32/min. Her mother states that she has used her albuterol inhaler several times a day for the past 3 days and twice during the previous night. She took an additional two puffs on her way to the emergency department, but her mother states that \u201cthe inhaler didn\u2019t seem to be helping so I told her not to take any more.\u201d What emergency measures are indicated? How should her long-term management be altered? A 14-year-old girl with a history of asthma requiring daily inhaled corticosteroid therapy and allergies to house dust mites, cats, grasses, and ragweed presents to the emergency department in mid-September, reporting a recent \u201ccold\u201d com-plicated by worsening shortness of breath and audible inspi-ratory and expiratory wheezing. She appears frightened and refuses to lie down but is not cyanotic. Her pulse is 120 bpm,"
        },
        {
            "id": "Pharmacology_Katzung_2624",
            "title": "Pharmacology_Katzung",
            "content": "Helge Eilers, MD, & Spencer Yost, MD An elderly man with type 2 diabetes mellitus and ischemic pain in the lower extremity is scheduled for femoral-to-popliteal artery bypass surgery. He has a history of hyper-tension and coronary artery disease with symptoms of stable angina. He can walk only half a block before pain in his legs forces him to stop. He has a 50-pack-year smoking history but stopped 2 years ago. Medications include atenolol, atorvastatin, and hydrochlorothiazide. The nurse in the preoperative holding area obtains the following vital signs: temperature 36.8\u00b0C (98.2\u00b0F), blood pressure 168/100 mm Hg, heart rate 78 bpm, oxygen saturation by pulse oximeter 96% while breathing room air, and pain 5/10 in the right lower leg after walking into the hospital. What anesthetic agents will you choose for his anesthetic plan? Why? Does the choice of anesthetic make a difference?"
        },
        {
            "id": "InternalMed_Harrison_20411",
            "title": "InternalMed_Harrison",
            "content": "Accompanying worsening airflow obstruction is an increased frequency of exacerbations (described below). Patients may also develop resting hypoxemia and require institution of supplemental oxygen. In the early stages of COPD, patients usually have an entirely normal physical examination. Current smokers may have signs of active smoking, including an odor of smoke or nicotine staining of fingernails. In patients with more severe disease, the physical examination is notable for a prolonged expiratory phase and may include expiratory wheezing. In addition, signs of hyperinflation include a barrel chest and enlarged lung volumes with poor diaphragmatic excursion as assessed by percussion. Patients with severe airflow obstruction may also exhibit use of accessory muscles of respiration, sitting in the characteristic \u201ctripod\u201d position to facilitate the actions of the sternocleidomastoid, scalene, and intercostal muscles. Patients may develop cyanosis, visible in the lips and nail beds."
        },
        {
            "id": "Pediatrics_Nelson_1800",
            "title": "Pediatrics_Nelson",
            "content": "Initial assessment Brief history, physical examination (auscultation, use of accessory muscles, heart rate, respiratory rate), PEF or FEV1, oxygen saturation, and other tests as indicated Severe exacerbation FEV1 or PEF <40% predicted/personal best Physical exam: severe symptoms at rest, accessory muscle use, chest retraction History: high-risk patient No improvement after initial treatment \u007f Oxygen \u007f Nebulized SABA plus Ipratropium, hourly or continuous \u007f Oral systemic corticosteroids \u007f Consider adjunct therapies Moderate exacerbation FEV1 or PEF 40\u201369% predicted/personal best Physical exam: moderate symptoms \u007f Inhaled SABA every 60 minutes \u007f Oral systemic corticosteroid \u007f Continue treatment 1\u20133 hours, provided there is improvement; make admit decision in <4 hours"
        },
        {
            "id": "First_Aid_Step2_1068",
            "title": "First_Aid_Step2",
            "content": "Supplemental oxygen titrated to > 90% SaO2 for > 15 hours a day and smoking cessation are the only interventions proven to improve survival in patients with COPD. \u25a0Chronic bronchitis (\u201cblue bloater\u201d): Cyanosis with mild dyspnea; productive cough. Patients are often overweight with peripheral edema, rhonchi, and early signs of hypercarbia/hypoxia. Look for the classic barrel chest, use of accessory chest muscles, JVD, end-expiratory wheezing, and muffed breath sounds. CXR: Hyperin\ufb02 ated lungs, \u2193 lung markings with fat diaphragms, and a thin-appearing heart and mediastinum. Parenchymal bullae or subpleural blebs (pathognomonic of emphysema) are also seen (see Figure 2.15-3). PFTs: \u2193 FEV1/FVC; normal or \u2193 FVC; normal or \u2191 TLC (emphysema, asthma); \u2193 DLCO (in emphysema). ABGs: Hypoxemia with acute or chronic respiratory acidosis (\u2191 PCO2). Blood cultures: Obtain if the patient is febrile."
        },
        {
            "id": "Pediatrics_Nelson_2321",
            "title": "Pediatrics_Nelson",
            "content": "Physical signs of bronchiolar obstruction include prolongation of the expiratory phase of breathing, nasal flaring, intercostal retractions, suprasternal retractions, and air trapping with hyperexpansion of the lungs. During the wheezing phase, percussion of the chest usually reveals only hyperresonance, but auscultation usually reveals diffuse wheezes and crackles throughout the breathing cycle. With more severe disease, grunting and cyanosis may be present. Routine laboratory tests are not required to confirm the diagnosis. It is important to assess oxygenation in severe cases of bronchiolitis. Pulse oximetry is adequate for monitoring oxygen saturation. Frequent, regular assessments and cardiorespiratory monitoring of infants are necessary because respiratory failure may develop precipitously in very tired infants even though blood gas values taken before rapid decompensation are reassuring."
        },
        {
            "id": "InternalMed_Harrison_19939",
            "title": "InternalMed_Harrison",
            "content": "The majority of the manifestations of respiratory disease present as abnormalities of auscultation. Wheezes are a manifestation of airway obstruction. While most commonly a sign of asthma, peribronchial edema in the setting of congestive heart failure can also result in diffuse wheezes, as can any other process that causes narrowing of small airways. For this reason, clinicians must take care not to attribute all wheezing to asthma. Rhonchi are a manifestation of obstruction of medium-sized airways, most often with secretions. In the acute setting, this manifestation may be a sign of viral or bacterial bronchitis. Chronic rhonchi suggest bronchiectasis or COPD. Stridor, a high-pitched, focal inspiratory wheeze, usually heard over the neck, is a manifestation of upper airway obstruction and should prompt expedited evaluation of the patient, as it can precede complete upper airway obstruction and respiratory failure."
        },
        {
            "id": "InternalMed_Harrison_201",
            "title": "InternalMed_Harrison",
            "content": "The following three brief scenarios of a patient with hemoptysis demonstrate three distinct patterns: A 46-year-old man presents to his internist with a chief complaint of hemoptysis. An otherwise healthy nonsmoker, he is recovering from an apparent viral bronchitis. This presentation pattern suggests that the small amount of blood-streaked sputum is due to acute bronchitis, so that a chest x-ray provides sufficient reassurance that a more serious disorder is absent. In the second scenario, a 46-year-old patient who has the same chief complaint but with a 100-pack-year smoking history, a productive morning cough, and episodes of blood-streaked sputum fits the pattern of carcinoma of the lung. Consequently, along with the chest x-ray, the physician obtains a sputum cytology examination and refers this patient for a chest computed tomography (CT) scan."
        },
        {
            "id": "InternalMed_Harrison_3597",
            "title": "InternalMed_Harrison",
            "content": "Fluid and Electrolyte Imbalances and Acid-Base Disturbances: Case Examples David B. Mount, Thomas D. DuBose, Jr. CASE 1 64e A 23-year-old woman was admitted with a 3-day history of fever, cough productive of blood-tinged sputum, confusion, and orthostasis. Past medical history included type 1 diabetes mellitus. A physical examination in the emergency department indicated postural hypo-tension, tachycardia, and Kussmaul respiration. The breath was noted to smell of \u201cacetone.\u201d Examination of the thorax suggested consolidation in the right lower lobe. Sodium 130 meq/L Potassium 5.0 meq/L Chloride 96 meq/L CO2 14 meq/L Blood urea nitrogen (BUN) 20 mg/dL Creatinine 1.3 mg/dL Glucose 450 mg/dL Pneumonic infiltrate, right lower lobe The diagnosis of the acid-base disorder should proceed in a stepwise fashion: 1. The normal anion gap (AG) is 8\u201310 meq/L, but in this case, the AG is elevated (20 meq/L). Therefore, the change in AG (\u0394AG) = ~10 meq/L. 2."
        },
        {
            "id": "InternalMed_Harrison_31953",
            "title": "InternalMed_Harrison",
            "content": "Cigarette smoking is responsible for 90% of chronic obstructive pulmonary disease. Within 1\u20132 years of beginning to smoke regularly, many young smokers will develop inflammatory changes in their small airways, although lung function measures of these changes do not predict development of chronic airflow obstruction. After 20 years of smoking, pathophysiologic changes in the lungs develop and progress proportional to smoking intensity and duration. Chronic mucous hyperplasia of the larger airways results in a chronic productive cough in as many as 80% of smokers >60 years of age. Chronic inflammation and narrowing of the small airways and/or enzymatic digestion of alveolar walls resulting in pulmonary emphysema can result in reduced expiratory airflow sufficient to produce clinical symptoms of respiratory limitation in ~15\u201325% of smokers."
        },
        {
            "id": "InternalMed_Harrison_3630",
            "title": "InternalMed_Harrison",
            "content": "A 78-year-old man was admitted with pneumonia and hyponatremia. Plasma Na+ concentration was initially 129 meq/L, decreasing within 3 days to 118\u2013120 meq/L despite fluid restriction to 1 L/d. A chest computed tomography (CT) revealed a right 2.8 \u00d7 1.6 cm infrahilar mass and postobstructive pneumonia. The patient was an active smoker. Past medical history was notable for laryngeal carcinoma treated 15 years prior with radiation therapy, renal cell carcinoma, peripheral vascular disease, and hypothyroidism. On review of systems, he denied headache, nausea, and vomiting. He had chronic hip pain, managed with acetaminophen with codeine. Other medications included cilostazol, amoxicillin/clavulanate, digoxin, diltiazem, and thyroxine. He was euvolemic on examination, with no lymphadenopathy and a normal chest examination. Na+ 120 K+ 4.3 Cl\u2212 89 HCO3\u2212 23 BUN 8 Creat 1.0 Glu 93 Alb 3.1 Ca 8.9 Phos 2.8 Mg 2.0 Plasma osm 248 mOsm/kg Cortisol 25 \u03bcg/dL TSH 2.6 Uric acid 2.7 mg/dL"
        },
        {
            "id": "InternalMed_Harrison_20167",
            "title": "InternalMed_Harrison",
            "content": "Clinical Features Patients are aware of increasing chest tightness, wheezing, and dyspnea that are often not or poorly relieved by their usual reliever inhaler. In severe exacerbations, patients may be so breathless that they are unable to complete sentences and may become cyanotic. Examination usually shows increased ventilation, hyperinflation, and tachycardia. Pulsus paradoxus may be present, but this is rarely a useful clinical sign. There is a marked fall in spirometric values and PEF. Arterial blood gases on air show hypoxemia, and PCO2 is usually low due to hyperventilation. A normal or rising PCO2 is an indication of impending respiratory failure and requires immediate monitoring and therapy. A chest roentgenogram is not usually informative but may show pneumonia or pneumothorax."
        },
        {
            "id": "Pharmacology_Katzung_4939",
            "title": "Pharmacology_Katzung",
            "content": "A 45-year-old man is brought to the local hospital emer-gency department by ambulance. His wife reports that he had been in his normal state of health until 3 days ago when he developed a fever and a productive cough. Dur-ing the last 24 hours he has complained of a headache and is increasingly confused. His wife reports that his medical history is significant only for hypertension, for which he takes hydrochlorothiazide and lisinopril, and that he is allergic to amoxicillin. She says that he developed a rash many years ago when prescribed amoxicillin for bron-chitis. In the emergency department, the man is febrile (38.7\u00b0C [101.7\u00b0F]), hypotensive (90/54 mmHg), tachypneic (36/min), and tachycardic (110/min). He has no signs of meningismus but is oriented only to person. A stat chest x-ray shows a left lower lung consolidation consistent with pneumonia. A CT scan is not concerning for lesions or elevated intracranial pressure. The plan is to start empiric antibiotics and perform a"
        },
        {
            "id": "Pharmacology_Katzung_1243",
            "title": "Pharmacology_Katzung",
            "content": "Tadalafil Cialis, Adcirca Cilostazol Generic, Pletal Pentoxifylline Generic, Trental Bertram G. Katzung, MD, PhD* A 55-year-old man noticed shortness of breath with exer-tion while on a camping vacation in a national park. He has a 15-year history of poorly controlled hypertension. The shortness of breath was accompanied by onset of swelling of the feet and ankles and increasing fatigue. On physical examination in the clinic, he is found to be mildly short of breath lying down but feels better sitting upright. Pulse is 100 bpm and regular, and blood pressure is 165/100 mm Hg. Crackles are noted at both lung bases, and his jugular venous pressure is elevated. The liver is enlarged, and there is 3+ edema of the ankles and feet. An echocardiogram shows an enlarged, poorly contracting heart with a left ven-tricular ejection fraction of about 30% (normal: 60%). The presumptive diagnosis is stage C, class III heart failure with reduced ejection fraction. What treatment is indicated?"
        },
        {
            "id": "Pharmacology_Katzung_7019",
            "title": "Pharmacology_Katzung",
            "content": "Her social history is significant for alcohol use (three to four glasses of wine/night). Her vital signs include the following: temperature 99.8\u00b0F, blood pressure 132/64 mm Hg, pulse 78 bpm, and respiratory rate 15/min. On physical examination, she had left upper abdominal tenderness with evidence of hepatomegaly and mild scleral icterus. Laboratory data revealed the following: alanine aminotransferase, 527 IU/L (normal 10\u201335 IU/L); aspartate aminotransferase, 425 IU/L (normal < 35 IU/L); and bilirubin, 2.9 mg/dL (normal 0.1\u20130.3 mg/dL). What medications do OTC cold and flu preparations typically contain? Which of the OTC medications might have contrib-uted to the patient\u2019s current symptoms? KH, a 55-year-old woman, presents to the emergency department with nausea, vomiting, and complaints of new-onset flu symptoms over the past several days. Her past medical history is significant for allergic rhinitis and chronic lower back pain secondary to a work-related fall 2 years ago. Her"
        },
        {
            "id": "Anatomy_Gray_562",
            "title": "Anatomy_Gray",
            "content": "A 53-year-old man presented to the emergency department with a 5-hour history of sharp pleuritic chest pain and shortness of breath. The day before he was on a long haul flight, returning from his holidays. He was usually fit and well and was a keen mountain climber. He had no previous significant medical history. On physical examination his lungs were clear, he was tachypneic at 24/min, and his saturation was reduced to 92% on room air. Pulmonary embolism was suspected and the patient was referred for a CT pulmonary angiogram. The study demonstrated clots within the right and left main pulmonary arteries. There was no pleural effusion, lung collapse, or consolidation. He was immediately started on subcutaneous enoxaparin and converted to oral anticoagulation over the course of a couple of days. The whole treatment lasted 6 months as no other risk factors (except immobilization during a long haul flight) were identified. There were no permanent sequelae."
        },
        {
            "id": "InternalMed_Harrison_20122",
            "title": "InternalMed_Harrison",
            "content": "The diagnosis of asthma is usually apparent from the symptoms of variable and intermittent airways obstruction, but must be confirmed by objective measurements of lung function. Lung Function Tests Simple spirometry confirms airflow limitation with a reduced FEV1, FEV1/FVC ratio, and PEF (Fig. 309-6). Reversibility is demonstrated by a >12% and 200-mL increase in FEV1 15 min after an inhaled short-acting \u03b22-agonist or in some patients by a 2to 4-week trial of oral corticosteroids (OCS) (prednisone or prednisolone 30\u201340 mg daily). Measurements of PEF twice daily may confirm the diurnal variations in airflow obstruction. Flow-volume loops show reduced peak flow and reduced maximum expiratory flow. Further lung function tests are rarely necessary, but whole-body plethysmography shows increased airway resistance and may show increased total lung capacity and residual volume. Gas diffusion is usually normal, but there may be a small increase in gas transfer in some patients."
        },
        {
            "id": "Pharmacology_Katzung_138",
            "title": "Pharmacology_Katzung",
            "content": "Mark von Zastrow, MD, PhD* A 51-year-old man presents to the emergency department due to acute difficulty breathing. The patient is afebrile and normotensive but anxious, tachycardic, and markedly tachy-pneic. Auscultation of the chest reveals diffuse wheezes. The physician provisionally makes the diagnosis of bronchial asthma and administers epinephrine by intramuscular injec-tion, improving the patient\u2019s breathing over several minutes. A normal chest X-ray is subsequently obtained, and the medical history is remarkable only for mild hypertension that is being treated with propranolol. The physician instructs the patient to discontinue use of propranolol, and changes the patient\u2019s antihypertensive medication to verapamil. Why is the physician correct to discontinue propranolol? Why is verapamil a better choice for managing hypertension in this patient? What alternative treatment change might the physi-cian consider?"
        },
        {
            "id": "InternalMed_Harrison_20409",
            "title": "InternalMed_Harrison",
            "content": "The three most common symptoms in COPD are cough, sputum production, and exertional dyspnea. Many patients have such symptoms for months or years before seeking medical attention. Although the development of airflow obstruction is a gradual process, many patients date the onset of their disease to an acute illness or exacerbation. A careful history, however, usually reveals the presence of symptoms prior to the acute exacerbation. The development of exertional dyspnea, often described as increased effort to breathe, heaviness, air hunger, or gasping, can be insidious. It is best elicited by a careful history focused on typical physical activities and how the patient\u2019s ability to perform them has changed. Activities involving significant arm work, particularly at or above shoulder level, are particularly difficult for patients with COPD. Conversely, activities that allow the patient to brace the arms and use accessory muscles of respiration are better tolerated. Examples of such"
        },
        {
            "id": "Pharmacology_Katzung_5118",
            "title": "Pharmacology_Katzung",
            "content": "A 45-year-old man with no significant medical history was admitted to the intensive care unit (ICU) 10 days ago after suffering third-degree burns over 40% of his body. He had been relatively stable until the last 24 hours. Now, he is febrile (39.5\u00b0C [103.1\u00b0F]), and his white blood cell count has risen from 8500 to 20,000/mm3. He has also had an episode of hypo-tension (86/50 mmHg) that responded to a fluid bolus. Blood cultures were obtained at the time of his fever and results are pending. The ICU attending physician is concerned about a bloodstream infection and decides to treat with empiric com-bination therapy directed against Pseudomonas aeruginosa. The combination therapy includes tobramycin. The patient weighs 70 kg (154 lb) and has an estimated creatinine clear-ance of 90 mL/min. How should tobramycin be dosed using once-daily and conventional dosing strategies? How should each regimen be monitored for efficacy and toxicity?"
        },
        {
            "id": "Pharmacology_Katzung_5216",
            "title": "Pharmacology_Katzung",
            "content": "Camille E. Beauduy, PharmD, & Lisa G. Winston, MD* A 60-year-old man presents to the emergency department with a 2-month history of fatigue, weight loss (10 kg), fevers, night sweats, and a productive cough. He is currently living with friends and has been intermittently homeless, spending time in shelters. He reports drinking about 6 beers per day. In the emergency department, a chest x-ray shows a right apical infiltrate. Given the high suspicion for pulmonary tuberculosis, the patient is placed in respiratory isolation. His first sputum smear shows many acid-fast bacilli, and an HIV test returns with a positive result. What drugs should be started for treatment of presumptive pulmonary tubercu-losis? Does the patient have a heightened risk of developing medication toxicity? If so, which medication(s) would be likely to cause toxicity?"
        },
        {
            "id": "Pharmacology_Katzung_1490",
            "title": "Pharmacology_Katzung",
            "content": "Ramin Sam, MD, Harlan E. Ives, MD, PhD, & David Pearce, MD A 65-year-old man has a history of diabetes and chronic kidney disease with baseline creatinine of 2.2 mg/dL. Despite five different antihypertensive drugs, his clinic blood pres-sure is 176/92 mm Hg; he has mild dyspnea on exertion and 2\u20133+ edema on exam. He has been taking furosemide 80 mg twice a day for 1 year now. At the clinic visit, hydrochlorothi-azide 25 mg daily is added for better blood pressure control and also to treat symptoms and signs of fluid overload. Two weeks later, the patient presents to the emergency depart-ment with symptoms of weakness, anorexia, and generalized malaise. His blood pressure is now 91/58 mm Hg, and he has lost 15 kg in 2 weeks. His laboratory tests are signifi-cant for a serum creatinine of 10.8 mg/dL. What has led to the acute kidney injury? What is the reason for the weight loss? What precautions could have been taken to avoid this hospitalization?"
        },
        {
            "id": "Pharmacology_Katzung_3731",
            "title": "Pharmacology_Katzung",
            "content": "James L. Zehnder, MD and edema and is tender to touch. Oxygen saturation by fingertip pulse oximeter while breathing room air is 87% (normal > 90%). Ultrasound reveals a deep vein thrombosis in the left lower extremity; chest computed tomography scan confirms the presence of pulmonary emboli. Laboratory blood tests indicate elevated d-dimer levels. What therapy is indicated acutely? What are the long-term therapy options? How long should she be treated? Should this indi-vidual use oral contraceptives? A 25-year-old woman presents to the emergency depart-ment complaining of acute onset of shortness of breath and pleuritic pain. She had been in her usual state of health until 2 days prior when she noted that her left leg was swollen and red. Her only medication was oral contraceptives. Family history was significant for a history of \u201cblood clots\u201d in mul-tiple members of the maternal side of her family. Physical examination demonstrates an anxious woman with stable vital signs. The left"
        },
        {
            "id": "InternalMed_Harrison_615",
            "title": "InternalMed_Harrison",
            "content": "Age, weight, height 2. Are you: Female and 55 years of age or older or male and 45 years of age of older? If yes, are you 70 years of age or older? 3. Do you take anticoagulant medications (\u201cblood thinners\u201d)? 4. Do you have or have you had any of the following heart-related conditions? Heart disease Heart attack within the last 6 months Angina (chest pain) 5. Do you have or have you ever had any of the following? Rheumatoid arthritis Kidney disease Liver disease Diabetes 6. Do you get short of breath when you lie flat? 7. Are you currently on oxygen treatment? 8. Do you have a chronic cough that produces any discharge or fluid? 9. Do you have lung problems or diseases? 10. Have you or any blood member of your family ever had a problem other than nausea with any anesthesia? If yes, describe: 11."
        },
        {
            "id": "First_Aid_Step2_1066",
            "title": "First_Aid_Step2",
            "content": "Antibiotics for bacterial infections; consider inhaled corticosteroids. Maintain bronchopulmonary hygiene (cough control, postural drainage, chest physiotherapy). Consider lobectomy for localized disease or lung transplantation for severe disease. Characterized by \u2193 lung function with airfow obstruction. Generally 2\u00b0 to chronic bronchitis or emphysema, which are distinguished as follows: Chronic bronchitis: Productive cough for > 3 months per year for two consecutive years. Emphysema: Terminal airway destruction and dilation that may be 2\u00b0 to smoking (centrilobular) or to \u03b11-antitrypsin deficiency (panlobular). Symptoms are minimal or nonspecifc until the disease is advanced. The clinical spectrum includes the following (most patients are a combination of the two phenotypes):"
        },
        {
            "id": "InternalMed_Harrison_20323",
            "title": "InternalMed_Harrison",
            "content": "The most common clinical presentation is a persistent productive cough with ongoing production of thick, tenacious sputum. Physical findings often include crackles and wheezing on lung auscultation, and some patients with bronchiectasis exhibit clubbing of the digits. Mild to moderate airflow obstruction is often detected on pulmonary function tests, overlapping with that seen at presentation with other conditions, such as chronic obstructive pulmonary disease (COPD). Acute exacerbations of bronchiectasis are usually characterized by changes in the nature of sputum production, with increased volume and purulence. However, typical signs and symptoms of lung infection, such as fever and new infiltrates, may not be present."
        },
        {
            "id": "Pharmacology_Katzung_808",
            "title": "Pharmacology_Katzung",
            "content": "A 68-year-old man presents with a complaint of light-headedness on standing that is worse after meals and in hot environments. Symptoms started about 4 years ago and have slowly progressed to the point that he is disabled. He has fainted several times but always recovers conscious-ness almost as soon as he falls. Review of symptoms reveals slight worsening of constipation, urinary retention out of proportion to prostate size, and decreased sweating. He is otherwise healthy with no history of hypertension, diabetes, or Parkinson\u2019s disease. Because of urinary retention, he was placed on the \u03b11 antagonist tamsulosin, but the fainting spells got worse. Physical examination revealed a blood pres-sure of 167/84 mm Hg supine and 106/55 mm Hg standing. There was an inadequate compensatory increase in heart rate (from 84 to 88 bpm), considering the degree of ortho-static hypotension. Physical examination is otherwise unre-markable with no evidence of peripheral neuropathy or parkinsonian"
        },
        {
            "id": "First_Aid_Step2_1069",
            "title": "First_Aid_Step2",
            "content": "ABGs: Hypoxemia with acute or chronic respiratory acidosis (\u2191 PCO2). Blood cultures: Obtain if the patient is febrile. Gram stain and sputum culture: Consider in the setting of fever or productive cough, especially if infltrate is seen on CXR. Acute exacerbations: O2, inhaled \u03b2-agonists (albuterol) and anticholinergics (ipratropium, tiotropium), IV +/\u2212 inhaled corticosteroids, antibiotics. Severe cases may beneft from noninvasive ventilation. Consider intubation in the setting of severe hypoxemia or hypercapnia, impending respiratory fatigue, or changes in mental status. Chronic: Smoking cessation, supplemental O2 (if resting PaO2 is \u2264 55 mmHg or SaO2 is \u2264 89%, or in the setting of cor pulmonale, pulmonary hypertension, a hematocrit > 55%, or nocturnal hypoxia), inhaled \u03b2-agonists, AB F IGU R E 2.1 5-3. Chronic obstructive pulmonary disease."
        },
        {
            "id": "Anatomy_Gray_554",
            "title": "Anatomy_Gray",
            "content": "A 65-year-old man was admitted to the emergency room with severe central chest pain that radiated to the neck and predominantly to the left arm. He was overweight and a known heavy smoker. On examination he appeared gray and sweaty. His blood pressure was 74/40 mm Hg (normal range 120/80 mm Hg). An electrocardiogram (ECG) was performed and demonstrated anterior myocardial infarction. An urgent echocardiograph demonstrated poor left ventricular function. The cardiac angiogram revealed an occluded vessel (Fig. 3.114A,B). Another approach to evaluating coronary arteries in patients is to perform maximum intensity projection (MIP) CT studies (Fig. 3.115A,B). This patient underwent an emergency coronary artery bypass graft and made an excellent recovery. He has now lost weight, stopped smoking, and exercises regularly."
        },
        {
            "id": "Pathology_Robbins_3049",
            "title": "Pathology_Robbins",
            "content": "Mostpatientswithemphysemaalsohavesignsandsymptomsofconcurrentchronicbronchitis,sincecigarettesmokingisariskfactorforboth. http://ebooksmedicine.net Chronic bronchitis is diagnosed on clinical grounds: it is defined by the presence of a persistent productive cough for at least 3 consecutive months in at least 2 consecutive years. It is common among cigarette smokers and urban dwellers in smog-ridden cities; some studies indicate that 20% to 25% of men in the 40to 65-year-old age group have the disease. In early stages of the disease, the cough raises mucoid sputum, but airflow is not obstructed. Some patients with chronic bronchitis have evidence of hyperresponsive airways, with intermittent bronchospasm and wheezing (asthmatic bronchitis), while other bronchitic patients, especially heavy smokers, develop chronic outflow obstruction, usually with associated emphysema (COPD). The distinctive feature of chronic bronchitis is hypersecretion of mucus, beginning in the large airways."
        },
        {
            "id": "Pharmacology_Katzung_5286",
            "title": "Pharmacology_Katzung",
            "content": "Harry W. Lampiris, MD, & Daniel S. Maddix, Pharm D The patient is a 37-year-old African-American man who lives in San Jose, California. He was recently incarcerated near Bakersfield, California and returned to Oakland about 3 months ago. He is currently experiencing one month of severe headache and double vision. He has a temperature of 38.6\u00b0C (101.5\u00b0F) and the physical exam reveals nuchal rigidity and right-sided sixth cranial nerve palsy. MRI of his brain is normal, and lumbar puncture reveals 330 WBC with 20% eosinophils, protein 75, and glucose 20. HIV test is negative, TB skin test is negative, CSF cryptococcal antigen is negative, and CSF gram stain is negative. Patient receives empiric therapy for bacterial meningitis with van-comycin and ceftriaxone, and is unimproved after 72 hours of treatment. After 3 days a white mold is identified growing from his CSF culture. What medical therapy would be most appropriate now?"
        },
        {
            "id": "Pharmacology_Katzung_914",
            "title": "Pharmacology_Katzung",
            "content": "David Robertson, MD, & Italo Biaggioni, MD* A 38-year-old man has been experiencing palpitations and headaches. He enjoyed good health until 1 year ago when spells of rapid heartbeat began. These became more severe and were eventually accompanied by throbbing headaches and drenching sweats. Physical examination revealed a blood pressure of 150/90 mm Hg and heart rate of 88 bpm. During the physical examination, palpation of the abdomen elicited a sudden and typical episode, with a rise in blood pressure to 210/120 mm Hg, heart rate to 122 bpm, profuse sweating, and facial pallor. This was accompanied by severe headache. What is the likely cause of his episodes? What caused the blood pressure and heart rate to rise so high during the examination? What treatments might help this patient?"
        }
    ],
    "scores": [
        0.02562988812988813,
        0.025390074783896818,
        0.025022792022792024,
        0.02269251963080314,
        0.02180447806562419,
        0.021709915244398005,
        0.021673377359411775,
        0.0212542756862023,
        0.020913832794241922,
        0.020513379872018615,
        0.019644936290537908,
        0.019424799622819428,
        0.019419306184012067,
        0.019327731092436976,
        0.019324122479462285,
        0.018672919923571306,
        0.018433571185864764,
        0.01837336704593342,
        0.01823607427055703,
        0.01818181818181818,
        0.01793758043758044,
        0.017820370663709804,
        0.017806267806267807,
        0.017713490099009903,
        0.017507645259938837,
        0.01748358528019545,
        0.017324133793310333,
        0.017323775388291517,
        0.017304393227418516,
        0.01715346846279743,
        0.016866619618913198,
        0.0166459455725929
    ]
}